How Malignant Hyperthermia Medications Work

Malignant hyperthermia is a life-threatening medical emergency that occurs in response to certain anesthetics. It is caused by abnormal muscle function, leading to excessive heat production and metabolic acidosis.

Gold Standard: Dantrolene

• Dantrolene works by inhibiting the release of calcium ions from the sarcoplasmic reticulum in skeletal muscle cells.
• This prevents the abnormal muscle contraction and heat production associated with malignant hyperthermia.
• It is the only medication specifically approved for the treatment of malignant hyperthermia.

Alternatives: Anesthetic Agents

• Haloperidol, midazolam, and ketamine are alternative anesthetics that may be used in patients with a history of malignant hyperthermia or those who are at risk for developing it.
• These agents have a lower risk of triggering malignant hyperthermia compared to traditional anesthetics like succinylcholine and volatile anesthetics.

Treatment Approach

The treatment approach for malignant hyperthermia involves immediate administration of dantrolene, along with supportive care measures such as cooling, hydration, and respiratory support. Alternative anesthetic agents may be used in conjunction with or instead of traditional anesthetics to reduce the risk of triggering a malignant hyperthermia episode.